Experience with FLT3 Inhibitor Midostaurin in Newly Diagnosed Acute Myeloid Leukemia Patients
Introduction With the introduction of FLT3 inhibitors in recent years, the presence of FLT3 mutation in newly diagnosed acute myeloid leukemia (AML) patients has become more important. it was observed that the addition of Midostaurin to remission induction and consolidation chemotherapy, brought a 2...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nizameddin KOCA
2021-03-01
|
| Col·lecció: | Turkish Journal of Internal Medicine |
| Matèries: | |
| Accés en línia: | https://dergipark.org.tr/tr/download/article-file/1552683 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|